PINK:IMNPQ
Delisted

Immune Pharmaceuticals Stock Signals

etoro logo Buy IMNPQ
*Your capital is at risk
$0.0010
+0 (+0%)
At Close: Jan 27, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Immune Pharmaceuticals, Inc.

General

Signal Type Signal Value Data
Score 0.000 210 days ( 37.50 %
Last Price $0.0010 0 %
Performance History
7 Days
$0.0010 $0.0010
0%
30 Days
$0.0010 $0.0010
0%
12 Mos
$0.0030 $0.0010
-66.67%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0010 - $0.0010
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jan 26, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 59.84
Signal Type Signal Value Importance Data
Trend - 12 mos -24.05 % Very High Width: 592.60 %
Pred. range - 12 mos N/A - $0.0023 High -100.00 % - 132.73 %
Short MA 12 mos Buy Very High May 09, 2022 - 182 days
Long MA 12 mos Buy Very High Sep 12, 2022 - 96 days
Short/Long MA 12 mos Buy Very High Sep 12, 2022 - 96 days
Pivot Long Sell Low Jan 26, 2023 - 2 days
RSI Long Pivot Signal Buy Low May 09, 2022 - 182 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT IMMUNE PHARMACEUTICALS, INC.
Immune Pharmaceuticals
Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various therapeutic agents for the treatment of immunologic and inflammatory diseases. The company's lead product candidate is bertilimumab, a human antibody, which is in Phase II clinical trials that targets eotaxin-1 for the treatment of bullous pemphigoid and ulcerative colitis. It is also developing NanoCyclo, a nano-encapsulated formulatio...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE